Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

5.44

+0.02 (0.37%)

At close: Feb 27, 2026, 4:00 PM EST

5.52

+0.08 (1.47%)

After-hours: Feb 27, 2026, 7:30 PM EST

Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	257	325	672	547	715	611
Market Cap Growth	30.82%	-51.64%	22.71%	-23.44%	17.04%	-
Enterprise Value	155	152	600	448	612	549
Last Close Price	5.44	6.88	17.37	15.25	23.89	22.00
PS Ratio	9.95	7.51	21.23	25.28	42.53	81.67
PB Ratio	3.47	2.42	30.54	20.58	61.93	49.39
P/TBV Ratio	4.07	2.61	57.66	33.06	580.25	487.96
P/FCF Ratio	-	-	-	-	96.09	-
P/OCF Ratio	-	-	-	-	77.58	-
EV/Sales Ratio	6.00	3.52	18.97	20.67	36.40	73.34
EV/FCF Ratio	-	-	-	-	82.24	-
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.02	0.04
Debt / FCF Ratio	-	-	-	-	0.03	-
Net Debt / Equity Ratio	-1.38	-1.10	-3.11	-3.20	-8.61	-4.10
Net Debt / EBITDA Ratio	1.47	3.01	1.32	1.68	1.61	1.22
Net Debt / FCF Ratio	1.41	2.17	1.38	1.49	-13.36	3.29
Asset Turnover	0.14	0.27	0.25	0.18	0.14	0.08
Quick Ratio	7.16	10.36	4.15	4.03	5.41	2.78
Current Ratio	7.69	11.14	4.62	4.41	5.69	2.99
Return on Equity (ROE)	-64.30%	-58.08%	-223.22%	-273.06%	-448.22%	-217.21%
Return on Assets (ROA)	-23.40%	-19.24%	-26.32%	-26.09%	-31.44%	-29.33%
Return on Capital Employed (ROCE)	-54.10%	-26.70%	-54.00%	-49.70%	-56.50%	-51.30%
Earnings Yield	-25.12%	-13.95%	-8.07%	-9.20%	-7.46%	-7.27%
FCF Yield	-28.25%	-20.89%	-7.37%	-10.45%	1.04%	-2.52%
Buyback Yield / Dilution	-7.98%	-24.69%	-15.21%	-8.58%	-8.78%	-8.85%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q